Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Crump

Showing results (11-20 of 183) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2009
Secondary breast cancer in Hodgkin's lymphoma survivorsMichael Crump, David Hodgson
Leukemia & Lymphoma|January 23, 2019
Improving CD20 antibody therapy: obinutuzumab in lymphoproliferative disordersAnca Prica, Michael Crump
Blood|January 26, 2011
How I treat relapsed and refractory Hodgkin lymphomaJohn Kuruvilla, Armand Keating, Michael Crump
Obstetric Medicine|September 1, 2016
Chronic lymphocytic leukaemia in pregnancy: a case report and literature reviewCynthia Maxwell, Rosheen Grady, Michael Crump
Clinical Lymphoma|July 2, 2005
A randomized phase III study of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin as salvage chemotherapy followed by posttransplantation rituximab maintenance therapy versus observation for treatment of aggressive B-Cell and T-Cell non-Hodgkin's lymphomaMichael Crump, Lois Shepherd, Boris Lin
Breast Cancer Research and Treatment|June 13, 2002
Purging of contaminating breast cancer cells from hematopoietic progenitor cell preparations using activation enhanced cell deathYicheng Zhang, Michael Crump, Stuart A Berge
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2008
Salvage therapy for relapsed/refractory diffuse large B cell lymphomaTara Seshadri, John Kuruvilla, Michael Crump, et al.
Current Problems in Cancer|June 3, 2006
Hodgkin's lymphomaRichard W Tsang, David C Hodgson, Michael Crump
Journal of the National Cancer Institute|January 8, 2004
Consolidation therapy with autologous bone marrow transplantation in adults with acute myeloid leukemia: a meta-analysisPaul C Nathan, Lillian Sung, Michael Crump, et al.
British Journal of Haematology|March 22, 2003
Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtypeKevin W Song, Peter Mollee, Armand Keating, et al.
Pageof 19

Showing results (11-20 of 183) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2009
Secondary breast cancer in Hodgkin's lymphoma survivorsMichael Crump, David Hodgson
Leukemia & Lymphoma|January 23, 2019
Improving CD20 antibody therapy: obinutuzumab in lymphoproliferative disordersAnca Prica, Michael Crump
Blood|January 26, 2011
How I treat relapsed and refractory Hodgkin lymphomaJohn Kuruvilla, Armand Keating, Michael Crump
Obstetric Medicine|September 1, 2016
Chronic lymphocytic leukaemia in pregnancy: a case report and literature reviewCynthia Maxwell, Rosheen Grady, Michael Crump
Clinical Lymphoma|July 2, 2005
A randomized phase III study of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin as salvage chemotherapy followed by posttransplantation rituximab maintenance therapy versus observation for treatment of aggressive B-Cell and T-Cell non-Hodgkin's lymphomaMichael Crump, Lois Shepherd, Boris Lin
Breast Cancer Research and Treatment|June 13, 2002
Purging of contaminating breast cancer cells from hematopoietic progenitor cell preparations using activation enhanced cell deathYicheng Zhang, Michael Crump, Stuart A Berge
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2008
Salvage therapy for relapsed/refractory diffuse large B cell lymphomaTara Seshadri, John Kuruvilla, Michael Crump, et al.
Current Problems in Cancer|June 3, 2006
Hodgkin's lymphomaRichard W Tsang, David C Hodgson, Michael Crump
Journal of the National Cancer Institute|January 8, 2004
Consolidation therapy with autologous bone marrow transplantation in adults with acute myeloid leukemia: a meta-analysisPaul C Nathan, Lillian Sung, Michael Crump, et al.
British Journal of Haematology|March 22, 2003
Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtypeKevin W Song, Peter Mollee, Armand Keating, et al.
Pageof 19